One of the four vaccine variants developed at the SRC VB VECTOR is ready for human testing.

Russian institutes of various departments united forces under the “Vaccines New Generation” Program to develop basically new approaches in creation anti-HIV/AIDS vaccines. Institute of Immunology (Russian Ministry of Public Health) and SRC VB VECTOR are two of the world leading research institutes developing various vaccines against this disease. In Russia vaccine is also developed at Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry RAS, Institute of Biomedical Chemistry RAMS, SRC of Special Clear Preparations and Biomedical Center (St. Petesburg).

One of the four vaccine variants developed at the SRC VB VECTOR is ready for human testing.

Russian institutes of various departments united forces under the “Vaccines New Generation” Program to develop basically new approaches in creation anti-HIV/AIDS vaccines. Institute of Immunology (Russian Ministry of Public Health) and SRC VB VECTOR are two of the world leading research institutes developing various vaccines against this disease. In Russia vaccine is also developed at Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry RAS, Institute of Biomedical Chemistry RAMS, SRC of Special Clear Preparations and Biomedical Center (St. Petesburg).

At the present time over 30 types of various anti-HIV vaccines are being developed in the world. Among difficulties in the developing there are HIV Virus features changeability and lack of adequate conventional animals models.

Both of the made in Russia sample vaccines passed almost every animal testing and during the next year will be ready for human testing as well. Specialists in various medical fields are participating in development of vaccine testing programs.

Anti-HIV vaccine development Global Center (that was organized by Group of 8 countries) will allow to unit different countries’ efforts in the vaccine development.